For the best user experience please use a browser to proceed.

Stock Research for Co-Diagnostics, Inc

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture an...

Basic Info:
  • Market Cap: 297.96M
  • Exchange: NASDAQ
  • Shares Float: 26,422,374
  • Shares Outstanding: 28,269,200
  • Percent Insiders: 6.52 %
  • Percent Institutions: 33.01 %
  • Revenue Per Employee: 1,218,362.05
Advanced Info:
  • Current Debt: 1.81M
  • Current Cash: 27.28M
  • Quick Ratio:
  • Debt to equity: 1.04
  • Put/call ratio: 0.57
  • Beta: -1.7732
Key Ratios:
  • P/E trailing 12 month: 10.67
  • P/E forward: 6.16
  • P/E trailing 12m high: 30.36
  • P/E trailing 12m low: 1.11
  • P/S trailing 12 month: 6.27
  • EV/S trailing 12 month: 5.98
  • P/B trailing 12 month: 5.9
  • PEG ratio:
Shorts:
  • Shares Short: 6,530,988
  • Shares Short Prev Month: 6,808,180
  • Days to Cover: 4.82
  • Short Percent Float: 23.10 %
  • Short Percent Outstanding: 23.00 %
Margins:
  • Gross Profit Margin: 69.00 %
  • EBITDA Margin: 53.00 %
  • Net Income Margin: 59.00 %
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date: None
Key Prices:
  • 52 Week High: 30.8
  • 52 Week Low: 0.9
  • 50 Day Moving Average: 13.15
  • 200 Day Moving Average: 16.06
Current Quarter Estimates:
  • Current Quarter EPS estimate: 0.46 - 0.49 (2020-12-31)
  • Current Quarter revenue estimate: 24.00M - 25.98M
Next Quarter Estimates:
  • Next Quarter EPS estimate: 0.46 - 0.55 (2021-03-31)
  • Next Quarter revenue estimate: 23.00M - 28.50M
As of: 2020-11-29
Upgrade / Downgrades:
CompanyActionDate
HC Wainwright & Co.Buy2020-12-15
HC Wainwright & Co.Buy2020-11-17
HC Wainwright & Co.Buy2020-08-14
Maxim GroupHold => Buy2020-05-20
HC Wainwright & Co.Buy2020-05-18
Maxim GroupBuy => Hold2020-03-03
HC Wainwright & Co.Buy2020-02-24
Maxim GroupBuy2019-04-09
H.C. WainwrightBuy2019-03-11
Insider Transactions:
NameActionSharesDate
Director: Serbin Richard SSell170002020-12-14
CFO: Benson Reed LSell1000002020-11-25
CFO: Benson Reed LSell895242020-11-25
CEO: Egan Dwight HSell1500002020-11-24
CEO: Egan Dwight HSell1343502020-11-24
Director: Serbin Richard SSell170002020-11-23
Director: Serbin Richard SSell500002020-05-28
Director: Serbin Richard SSell250002020-05-28
Director: Serbin Richard SSell250002020-05-19
Latest News:
Forget Snowflake! Buy This Ultra-High-Growth StockThe Motley Fool2021-01-15 07:07:00 EDT
3 Top Coronavirus Stocks to Buy Right NowThe Motley Fool2021-01-06 11:55:00 EDT
These Were the 3 Best Coronavirus Stocks of 2020The Motley Fool2021-01-01 06:10:00 EDT
CODX Dec 2020 8.500 callYahoo Finance2020-12-31 14:12:00 EDT
These Were the 5 Top Genetics Stocks of 2020The Motley Fool2020-12-31 11:53:00 EDT
CODX Dec 2020 18.000 callYahoo Finance2020-12-31 07:12:00 EDT
CODX Dec 2020 10.500 putYahoo Finance2020-12-31 07:12:00 EDT
Co-Diagnostics, Inc. (C97.F)Yahoo Finance2020-12-23 11:57:00 EDT
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020The Motley Fool2020-12-23 06:55:00 EDT
Co-Diagnostics Inc Registered Shs BuyBusiness Insider2020-12-15 17:28:00 EDT
These Were the 10 Best Healthcare Stocks of 2020The Motley Fool2020-12-15 06:35:00 EDT
Latest Posts:
Not available at this time..
Apple
Amazon
Okta
Sumo Logic
Slack
Palantir
DoorDash
Airbnb
Co-Diagnostics, Inc
(NASDAQ:CODX)
Co-Diagnostics, Inc

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 39
Next Earnings Date: 2021-04-06
Keywords: co-diagnostics
  • Return on equity score:
  • Return on assets score:
  • P/E ratio score:
  • P/B ratio score:
  • P/S ratio score:
  • Revenue growth score:
387 Followers
3473 Followers
Avg: 
 (40 review, 41 jobs)
Basic Info:
  • Market Cap: 297.96M
  • Exchange: NASDAQ
  • Shares Float: 26,422,374
  • Shares Outstanding: 28,269,200
  • Percent Insiders: 6.52 %
  • Percent Institutions: 33.01 %
  • Revenue Per Employee: 1,218,362.05
Advanced Info:
  • Current Debt: 1.81M
  • Current Cash: 27.28M
  • Quick Ratio:
  • Debt to equity: 1.04
  • Put/call ratio: 0.57
  • Beta: -1.7732
Key Ratios:
  • P/E trailing 12 month: 10.67
  • P/E forward: 6.16
  • P/E trailing 12m high: 30.36
  • P/E trailing 12m low: 1.11
  • P/S trailing 12 month: 6.27
  • EV/S trailing 12 month: 5.98
  • P/B trailing 12 month: 5.9
  • PEG ratio:
Shorts:
  • Shares Short: 6,530,988
  • Shares Short Prev Month: 6,808,180
  • Days to Cover: 4.82
  • Short Percent Float: 23.10 %
  • Short Percent Outstanding: 23.00 %
Margins:
  • Gross Profit Margin: 69.00 %
  • EBITDA Margin: 53.00 %
  • Net Income Margin: 59.00 %
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date: None
Key Prices:
  • 52 Week High: 30.8
  • 52 Week Low: 0.9
  • 50 Day Moving Average: 13.15
  • 200 Day Moving Average: 16.06
Current Quarter Estimates:
  • Current Quarter EPS estimate: 0.46 - 0.49 (2020-12-31)
  • Current Quarter revenue estimate: 24.00M - 25.98M
Next Quarter Estimates:
  • Next Quarter EPS estimate: 0.46 - 0.55 (2021-03-31)
  • Next Quarter revenue estimate: 23.00M - 28.50M
As of: 2020-11-29
Analyst Opinions:
Analyst Trends:
Debt / Cash Analysis:
Technical Price Pattern Alerts:

E-mail me when special technical pattern forms. 🔥

Institution & Insiders Analysis:
Find the next Tesla with traders

Find out why is Tesla good with other traders and discover the next big things in the stock market. 🚀🚀🚀

Short Analysis:
Margins and Revenue:
Income Statement:
Number of Employees:
Earnings Estimate:
Balance Sheets:
Cashflows:
World Website Ranking:
Google Trends: